Tesmilifene may enhance breast cancer chemotherapy by killing a clone of aggressive, multi-drug resistant cells through its action on the p-glycoprotein pump-Reference-Cited by-同舟云学术

Tesmilifene may enhance breast cancer chemotherapy by killing a clone of aggressive, multi-drug resistant cells through its action on the p-glycoprotein pump

Published:2006-01 Issue:4 Volume:66 Page:715-731
ISSN:0306-9877
Container-title:Medical Hypotheses
language:en
Short-container-title:Medical Hypotheses

Author:

Vincent Mark

Publisher

Elsevier BV

Subject

General Medicine

Reference96 articles.

1. Phase III study of N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethanamine (BMS-217380-01) combined with doxorubicin versus doxorubicin alone in metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA.19;Reyno;J Clin Oncol,2004

2. Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group;Marty;J Clin Oncol,2005

3. Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group;Slamon;J Clin Oncol,2005

4. HER2-specific cytotoxic activity of lymphokine-activated killer cells in the presence of trastuzumab;Yamaguchi;Anticancer Res,2005

5. Targeting fatty acid synthase-driven lipid rafts: a novel strategy to overcome trastuzumab resistance in breast cancer cells;Menendez;Med Hypoth,2005

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between MDR1 gene of gastrointestinal tumors, the expression of P-glycoprotein and resistance to chemotherapeutic drugs;Oncology Letters;2017-07-20

2. Dendrogenin A: A Mammalian Metabolite of Cholesterol with Tumor Suppressor and Neurostimulating Properties;Current Medicinal Chemistry;2015-10-19

3. Cholesterol epoxide hydrolase and cancer;Current Opinion in Pharmacology;2012-12

4. Reversal of ATP-binding cassette drug transporter activity to modulate chemoresistance: why has it failed to provide clinical benefit?;Cancer and Metastasis Reviews;2012-10-24

5. Three Decades of P-gp Inhibitors: Skimming Through Several Generations and Scaffolds;Current Medicinal Chemistry;2012-03-01